Grünenthal Group

Grünenthal Group

Private
AachenHealthcare & Life Scienceshttps://www.grunenthal.com/

Last Round

Debt

Nov 14, 2025

Total Funding Raised

$1.7B

Company Overview

Grünenthal Group is a pharmaceutical company that develops and commercializes treatments and technologies for pain management and related diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Pharma Supply Chain, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share, Services & Consulting

AI Layer

Application

Keywords

pain managementnon-opioid pain therapypharmaceutical companydrug developmentneuropathic painchronic pain treatmentspecialty pharmaanalgesicspainkillersdrug discoveryopioid analgesicstopical pain reliefpharma M&Aopioid-induced constipationcontract manufacturingCMOAI in drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Grünenthal Group Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Grünenthal Group Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtNov 14, 2025
DebtNov 27, 2024
DebtApr 25, 2023
DebtFeb 12, 2021

Key People

Founding team and executive leadership

elfriede ventker

CEO

Executive Team

Gabriel Baertschi

Chairman Of The Corporate Executive Board And Chief Executive Officer

Executive Team

Anne Großkopff

CFO Forschung & Entwicklung

Executive Team

Christopher Knippen

Change & Communication Lead CFO Area

Executive Team

Grünenthal Group Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 14, 2025

    $202M debt round completed.

  • Nov 13, 2025

    Monthly visitors grew 33% MoM, reaching 44.7K.

Grünenthal Group Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Grünenthal Group Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Grünenthal Group's valuation, stock price, and market status.

Firmographic Details

HeadquartersAachen
Employee Range4,628
Year Founded1946
Last FundingNov 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.